Iron Triangle Partners LP
Regulatory profile
From Form ADV, the SEC filer profile, 13D/13G type codes and N-CEN, never from the name.
Portfolio style
Measured from the filed 13F common-share book for Dec 31, 2025, never from the firm's own description.
Closest benchmark: the S&P 500 as of 2025-12-31, active share 96.6%; sector active share 90.4% against the combined 13F book's sector weights.
Over time 24 measured quarters
How the bands are measured
Style bands measure the filed 13F common-share book each closed quarter, tested in this order. Unknown: under $10,000,000 of valued equity or 5 stocks. Index-like (100+ stocks): active share of 20% or less against the closest benchmark, which is the S&P 500, S&P MidCap 400, S&P SmallCap 600, Russell 1000, Russell 2000, Nasdaq-100 or Dow Jones Industrial Average (weighted by an index-tracking fund's reported holdings or the index's constituents nearest the quarter end, over the names resolved to companies, and only when those are 90%+ of its weight) or every 13F filer's combined book, or index series holding 80%+ of the registered fund assets it advises (N-CEN) and equal to 50%+ of its book. Systematic-like: 500+ stocks, 100%+ annual turnover and a top 10 weight of 25% or less. Concentrated: a top 10 weight of 60%+ or 12 or fewer effective positions. Diversified active: none of these. Turnover is the smaller of buys and sells over average equity value, summed over four quarters: low under 30%, high 100%+. Horizon is the value-weighted number of quarters each position has been held: short under 4, long 12+.
Clone Performance
Build a hypothetical price-return history from this filer's public 13F holdings.
View clone backtestPortfolio Concentration
27 tracked positions · as of Dec 31, 2025 · Δ vs Sep 30, 2025Portfolio Trend
Sector Breakdown
As of Dec 31, 2025| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $874,680,134 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| AHCO | AdaptHealth Corp. | +684,871 | 2,609,003 | $25,985,669 | |
| BKD | Brookdale Senior Living Inc. | +653,302 | 3,491,663 | $37,675,043 | |
| VCYT | Veracyte, Inc. | +495,391 | 980,391 | $41,274,461 | |
| DOCS | Doximity, Inc. | +476,568 | 686,568 | $30,401,231 | |
| IDYA | IDEAYA Biosciences, Inc. | +197,484 | 467,484 | $16,160,921 | |
| JAZZ | Jazz Pharmaceuticals plc | +142,170 | 292,170 | $49,668,900 | |
| CRL | Charles River Laboratories International, Inc. | +111,728 | 379,728 | $75,748,141 | |
| RGEN | Repligen Corp | +50,474 | 320,474 | $52,512,869 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| ISRG | Intuitive Surgical Inc | 94,459 | $53,497,799 | |
| BSX | Boston Scientific Corp | 420,773 | $40,120,705 | |
| WAT | Waters Corp | 105,167 | $39,945,581 | |
| BRKR | Bruker Corp | 794,380 | $37,423,241 | |
| VRTX | Vertex Pharmaceuticals Inc | 76,910 | $34,867,917 | |
| FTRE | Fortrea Holdings Inc. | 1,986,333 | $34,264,244 | |
| MMSI | Merit Medical Systems Inc | 385,660 | $33,992,072 | |
| TECH | BIO-TECHNE Corp | 467,409 | $27,488,323 | |
| ATEC | Alphatec Holdings, Inc. | 1,285,685 | $27,050,812 | |
| NVST | Envista Holdings Corp | 1,186,704 | $25,763,343 | |
| UNH | Unitedhealth Group Inc | 70,126 | $23,149,293 | |
| ABT | Abbott Laboratories | 175,333 | $21,967,471 | |
| BHVN | Biohaven Ltd. | 958,336 | $10,819,613 | |
| XENE | Xenon Pharmaceuticals Inc. | 233,688 | $10,473,896 | |
| DNTH | Dianthus Therapeutics, Inc. | 230,730 | $9,508,383 | |
| MLYS | Mineralys Therapeutics, Inc. | 257,085 | $9,329,614 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| DXCM | Dexcom Inc | 850,000 | $57,196,500 | |
| ABBV | AbbVie Inc. | 200,326 | $46,383,482 | |
| MDT | Medtronic plc | 453,347 | $43,176,768 | |
| GKOS | GLAUKOS Corp | 342,804 | $27,955,666 | |
| THC | Tenet Healthcare Corp | 137,448 | $27,907,441 | |
| — | 500,000 | $27,355,000 | ||
| ADPT | Adaptive Biotechnologies Corp | 1,820,915 | $27,240,888 | |
| MDGL | Madrigal Pharmaceuticals, Inc. | 58,378 | $26,775,653 | |
| GH | Guardant Health, Inc. | 400,000 | $24,992,000 | |
| CAH | Cardinal Health Inc | 138,011 | $21,662,206 | |
| NBIX | Neurocrine Biosciences Inc | 131,390 | $18,444,528 | |
| WST | West Pharmaceutical Services Inc | 70,000 | $18,363,100 | |
| — | 1,971,260 | $15,533,529 | ||
| ARGX | Argenx SE | 9,900 | $7,301,844 | |
| No positions match the current search. | ||||
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| CRL |
Charles River Laboratories International, Inc.
Healthcare
|
Added | 379,728 | $75,748,141 | 8.66% | |
| ISRG |
Intuitive Surgical Inc
Healthcare
|
NEW | 94,459 | $53,497,799 | 6.12% | |
| RGEN |
Repligen Corp
Healthcare
|
Added | 320,474 | $52,512,869 | 6.00% | |
| JAZZ |
Jazz Pharmaceuticals plc
Healthcare
|
Added | 292,170 | $49,668,900 | 5.68% | |
| VCYT |
Veracyte, Inc.
Healthcare
|
Added | 980,391 | $41,274,461 | 4.72% | |
| BSX |
Boston Scientific Corp
Healthcare
|
NEW | 420,773 | $40,120,705 | 4.59% | |
| WAT |
Waters Corp
Healthcare
|
NEW | 105,167 | $39,945,581 | 4.57% | |
| BKD |
Brookdale Senior Living Inc.
Healthcare
|
Added | 3,491,663 | $37,675,043 | 4.31% | |
| LLY |
ELI LILLY & Co
Healthcare
|
Reduced | 35,045 | $37,662,164 | 4.31% | |
| BRKR |
Bruker Corp
Healthcare
|
NEW | 794,380 | $37,423,241 | 4.28% | |
| VRTX |
Vertex Pharmaceuticals Inc
Healthcare
|
NEW | 76,910 | $34,867,917 | 3.99% | |
| CVS |
CVS HEALTH Corp
Healthcare
|
Reduced | 432,457 | $34,319,787 | 3.92% | |
| FTRE |
Fortrea Holdings Inc.
Healthcare
|
NEW | 1,986,333 | $34,264,244 | 3.92% | |
| MMSI |
Merit Medical Systems Inc
Healthcare
|
NEW | 385,660 | $33,992,072 | 3.89% | |
| BTSG |
BrightSpring Health Services, Inc.
Healthcare
|
Reduced | 897,427 | $33,608,641 | 3.84% | |
| DOCS |
Doximity, Inc.
Healthcare
|
Added | 686,568 | $30,401,231 | 3.48% | |
| TECH |
BIO-TECHNE Corp
Healthcare
|
NEW | 467,409 | $27,488,323 | 3.14% | |
| ATEC |
Alphatec Holdings, Inc.
Healthcare
|
NEW | 1,285,685 | $27,050,812 | 3.09% | |
| AHCO |
AdaptHealth Corp.
Healthcare
|
Added | 2,609,003 | $25,985,669 | 2.97% | |
| NVST |
Envista Holdings Corp
Healthcare
|
NEW | 1,186,704 | $25,763,343 | 2.95% | |
| UNH |
Unitedhealth Group Inc
Healthcare
|
NEW | 70,126 | $23,149,293 | 2.65% | |
| ABT |
Abbott Laboratories
Healthcare
|
NEW | 175,333 | $21,967,471 | 2.51% | |
| IDYA |
IDEAYA Biosciences, Inc.
Healthcare
|
Added | 467,484 | $16,160,921 | 1.85% | |
| BHVN |
Biohaven Ltd.
Healthcare
|
NEW | 958,336 | $10,819,613 | 1.24% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
NEW | 233,688 | $10,473,896 | 1.20% | |
| DNTH |
Dianthus Therapeutics, Inc.
Healthcare
|
NEW | 230,730 | $9,508,383 | 1.09% | |
| MLYS |
Mineralys Therapeutics, Inc.
Healthcare
|
NEW | 257,085 | $9,329,614 | 1.07% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.